Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis

Published:2022-11 Issue:2 Volume:160 Page:433-443
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Wang Jingjing,Huang Yan,Zhao Feng,Chen Jianhui,He Ling,Liu Zheran,Pei Yiyan,Wei Zhigong,Li Ruidan,Ai Ping,Peng Xingchen

Funder

National Natural Science Foundation of China

Sichuan Province Science and Technology Support Program

West China Nursing Discipline Development Special Fund Project

Technology Innovation Project of Chengdu Science and Technology Bureau

Postdoctoral research and Development Fund and Translational medicine fund of West China Hospital

National Key R&D Program of China

the 1·3·5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University

the project of Sichuan Science and Technology Bureau

Clinical Incubation Program of West China Hospital, SCU

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-022-04162-w.pdf

Reference25 articles.

1. Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353(8):811–822

2. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(6):803–820

3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

4. Balañá C, Vaz MA, Lopez D, de la Peñas R, García-Bueno JM, Molina-Garrido MJ, Sepúlveda JM, Cano JM, Bugés C, Sanz SM et al (2014) Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain. Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico 16(3):273–279

5. Roldan Urgoiti GB, Singh AD, Easaw JC (2012) Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme. J Neurooncol 108(1):173–177

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and adverse events of bevacizumab combined with temozolomide in the treatment of glioma: a systemic review and meta-analysis of randomized controlled trials;Frontiers in Medicine;2024-07-02

2. A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma;Journal of Neuro-Oncology;2023-12-28

3. Safety and feasibility of intra-arterial delivery of teniposide to high grade gliomas after blood–brain barrier disruption: a case series;Journal of NeuroInterventional Surgery;2023-12-07

4. TTFields Prolonged the PFS of Epithelioid Glioblastoma Patient: A Case Report;Brain Sciences;2023-04-07

5. Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma;Neuro-Oncology Advances;2023-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3